An Overview of a Novel, Water-Soluble Undenatured Type II Collagen (NEXT-II)

2015 ◽  
Vol 34 (3) ◽  
pp. 255-262 ◽  
Author(s):  
Orie Yoshinari ◽  
Hiroyoshi Moriyama ◽  
Yoshiaki Shiojima
2013 ◽  
Vol 23 (7) ◽  
pp. 491-499 ◽  
Author(s):  
Orie Yoshinari ◽  
Palma Ann Marone ◽  
Hiroyoshi Moriyama ◽  
Manashi Bagchi ◽  
Yoshiaki Shiojima

2013 ◽  
Vol 16 (11) ◽  
pp. 1039-1045 ◽  
Author(s):  
Orie Yoshinari ◽  
Yoshiaki Shiojima ◽  
Hiroyoshi Moriyama ◽  
Junichi Shinozaki ◽  
Takahisa Nakane ◽  
...  

2015 ◽  
Vol 5 (7) ◽  
pp. 251
Author(s):  
Orie Yoshinari ◽  
Hiroyoshi Moriyama ◽  
Yoshiaki Shiojima ◽  
Hiromi Miyawaki

Background: Oral administration of a novel water-soluble undenatured type II collagen (NEXT-II®) has been demonstrated to ameliorate the signs and symptoms of rheumatoid arthritis (RA) in animal models. In the present investigation, we conducted a pilot study to examine the efficacy and safety of NEXT-II® in borderline subjects defined as healthy and non-diseased state, but with potential risks in knee joint health.  Method: We employed Western Ontario McMaster Index (WOMAC) score and Visual Analog Scale (VAS) scores to assess the extent of improvement in the knee joints in these volunteers following supplementation of 40 mg NEXT-II® (10 mg as undenatured type II collagen) over a period of 12 weeks.   Result: The results demonstrated that NEXT-II® treatment significantly reduced WOMAC and VAS scores compared to subjects at baseline. Specifically, in the evaluation using VAS, the borderline subjects at resting, walking, and going up and down the stairs revealed significant improvement when compared to the baseline.  Conclusion: The results of the studies demonstrated that NEXT-II® might be an ingredient which is safe and effective in the application of dietary supplement in ameliorating joint pain and symptoms of the borderline subjects without any adverse events. 


2021 ◽  
Vol 3 (5) ◽  
pp. 1122-1132
Author(s):  
Ana Paula Costa ◽  
Carlos Monteiro ◽  
Verine Cunha Teixeira ◽  
Bruno da Silva Schwarstzhoupt ◽  
Patrícia Mota Ferreira ◽  
...  

2013 ◽  
Vol 10 (1) ◽  
pp. 48 ◽  
Author(s):  
James P Lugo ◽  
Zainulabedin M Saiyed ◽  
Francis C Lau ◽  
Jhanna Pamela L Molina ◽  
Michael N Pakdaman ◽  
...  

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1764-1764
Author(s):  
Kazim Sahin ◽  
Cemal Orhan ◽  
Mehmet Tuzcu ◽  
Nurhan Sahin ◽  
Vijaya Juturu

Abstract Objectives To study the effect of exercise training alone and or in combination with marine phytoplankton (Oceanix, OCX) and undenatured type II collagen (UCII) supplementation on the endurance capacity, pro-inflammatory markers, and antioxidant defense markers in rats. Methods A total of 28 male Wistar albino rats were randomly divided into four groups (n  =  7) (i) No exercise and no OCX (Control), (ii) Exercise, (iii) Exercise +OCX-I (2.55 mg d/rat) + UC-II (4 mg), iv) Exercise + OCX-2 (5.1 mg d/rat)+UC-II (4 mg). Levels of cholesterol, triglyceride, proinflammatory cytokines (IL-1β, IL-6, TNF-α, COMP, CRP), lactate and malondialdehyde (MDA) levels activities of antioxidant enzymes were determined in all the groups. Results Run to exhaustion (minutes) improved in the OCX + UC-II treated groups. Levels of cholesterol, triglyceride, proinflammatory cytokines (IL-1β, IL-6, TNF-α, COMP, CRP) decreased by OCX + UC-II supplementation. A significant decrease in lactate and malondialdehyde (MDA) levels and an increase in activities of antioxidant enzymes were observed in the combination of exercise and OCX + UC-II groups. Exercise + OCX + UC-II treated had lower TNF-α and IL-1β levels in muscle than exercise and control rats (P < 0.001). Muscle sterol regulatory element-binding protein 1c (SREBP-1c), liver X receptors (LXR), ATP citrate lyase (ACLY) and fatty acid synthase (FAS) levels in the exercise + OCX + UC-II group were lower than all groups (P < 0.05). The effectiveness of the high dose of OCX was more pronounced than the low dose of OCX. Conclusions These results suggest OCX and UC-II with exercise may enhance lipid metabolism by regulation of gene products involved in lipid and antioxidant metabolism including SREBP-1c, -γ, LXR, ACLY and FAS in rats. Funding Sources Lonza.


Sign in / Sign up

Export Citation Format

Share Document